Are there new clinical parameters useful to predict response in chronic myeloid leukemia in the imatinib era?
作者信息
Breccia Massimo, Alimena Giuliana
出版信息
Leuk Res. 2009 Nov;33(11):1450-1. doi: 10.1016/j.leukres.2009.06.022. Epub 2009 Jul 16.
Abstract
摘要
相似文献
1
Are there new clinical parameters useful to predict response in chronic myeloid leukemia in the imatinib era?在伊马替尼时代，是否有新的临床参数有助于预测慢性髓性白血病的反应？
Leuk Res. 2009 Nov;33(11):1450-1. doi: 10.1016/j.leukres.2009.06.022. Epub 2009 Jul 16.
2
Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?伊马替尼早期诱导的骨髓抑制能否预测晚期慢性髓性白血病患者的血液学反应？
J Clin Oncol. 2003 Nov 15;21(22):4255-6. doi: 10.1200/JCO.2003.99.209.
3
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.接受伊马替尼治疗的慢性粒细胞白血病或胃肠道间质瘤患者发生低丙种球蛋白血症。
Haematologica. 2008 Aug;93(8):1252-5. doi: 10.3324/haematol.12642. Epub 2008 Jun 2.
4
Mean cell volume can be an early predictor for the cytogenetic response of chronic myeloid leukemia patients treated with imatinib?
Leuk Res. 2009 Nov;33(11):1459-62. doi: 10.1016/j.leukres.2009.04.017. Epub 2009 May 15.
5
Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.一名慢性髓性白血病患者在接受甲磺酸伊马替尼治疗后发生多发性骨髓瘤。
Oncologist. 2005 Jun-Jul;10(6):457-8. doi: 10.1634/theoncologist.10-6-457.
6
Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.在甲磺酸伊马替尼治疗慢性髓性白血病期间发生的急性髓性白血病，且不存在新的细胞遗传学异常。
Leuk Res. 2007 Nov;31(11):1589-92. doi: 10.1016/j.leukres.2007.01.022. Epub 2007 Mar 27.
7
Clinical characteristics and hematologic responses to Imatinib in patients with chronic phase myeloid leukemia (CML) at Cipto Mangunkusumo Hospital.
Acta Med Indones. 2010 Jan;42(1):2-5.
8
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.慢性髓性白血病完全细胞遗传学缓解后与伊马替尼相关的骨髓再生障碍
J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.
9
Hematological and molecular response evaluation of CML patients on imatinib.伊马替尼治疗的慢性粒细胞白血病患者的血液学和分子反应评估
J Assoc Physicians India. 2007 Feb;55:109-13.
10
STI-571 (Gleevec) in the treatment of chronic myeloid leukaemia.
Natl Med J India. 2002 Sep-Oct;15(5):298.
Zotero 插件